Prosecution Insights
Last updated: May 29, 2026

Recursion Pharmaceuticals Inc.

6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
2
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (50%)
1
Easy (17%)
2
Unknown (33%)

Rejection Statute Mix

BucketCases
§103 only3 (50%)
§112 only1 (17%)
No statute on record2 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
67% of docket
0
Information Tech
0% of docket
1
Communications
17% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
17% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TORRICO-LOPEZ, ALAN 1 28.4% +39.0%
VILLENA, MARK 1 70.4% +15.4%
NEGIN, RUSSELL SCOTT 1 55.9% +33.6%
PLAYER, ROBERT AUSTIN 1 16.7% +90.9%
ARIETI, RUTH SOPHIA 1 45.2% +73.6%
HAYES, JONATHAN EDWARD 1 34.8% +22.8%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17439450 PROCESS CONTROL IN CELL BASED ASSAYS PLAYER, ROBERT AUSTIN 86d overdue
18937359 SYSTEMS AND METHODS FOR EVALUATING QUERY PERTURBATIONS TORRICO-LOPEZ, ALAN 31d overdue

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17439450 PROCESS CONTROL IN CELL BASED ASSAYS PLAYER, ROBERT AUSTIN 86d overdue
17101545 HIGH THROUGHPUT GENE EDITING SYSTEM AND METHOD ARIETI, RUTH SOPHIA 60d overdue
18937359 SYSTEMS AND METHODS FOR EVALUATING QUERY PERTURBATIONS TORRICO-LOPEZ, ALAN 31d overdue
18505748 UTILIZING COMPOUND-PROTEIN MACHINE LEARNING REPRESENTATIONS TO GENERATE BIOACTIVITY PREDICTIONS NEGIN, RUSSELL SCOTT 5d overdue
16538475 DESIGN OF MOLECULES HAYES, JONATHAN EDWARD 5d overdue
18750828 GENERATING LARGE-LANGUAGE-MODEL COMPATIBLE SEQUENTIAL ATTACHMENT-BASED FRAGMENT EMBEDDING MOLECULAR REPRESENTATIONS VILLENA, MARK 15d

Top Art Units

Art UnitApps
1686 2
3625 1
2658 1
1635 1
1685 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18937359 SYSTEMS AND METHODS FOR EVALUATING QUERY PERTURBATIONS TORRICO-LOPEZ, ALAN 3625 Other Non-Final OA 31d overdue Pending Nov 05, 2024
18750828 GENERATING LARGE-LANGUAGE-MODEL COMPATIBLE SEQUENTIAL ATTACHMENT-BASED FRAGMENT EMBEDDING MOLECULAR REPRESENTATIONS VILLENA, MARK 2658 §103 Non-Final OA 15d Pending Jun 21, 2024
18505748 UTILIZING COMPOUND-PROTEIN MACHINE LEARNING REPRESENTATIONS TO GENERATE BIOACTIVITY PREDICTIONS NEGIN, RUSSELL SCOTT 1686 §112 Final Rejection 5d overdue Pending Nov 09, 2023
17439450 PROCESS CONTROL IN CELL BASED ASSAYS PLAYER, ROBERT AUSTIN 1686 Other Final Rejection 86d overdue Pending Sep 15, 2021
17101545 HIGH THROUGHPUT GENE EDITING SYSTEM AND METHOD ARIETI, RUTH SOPHIA 1635 §103 Final Rejection 60d overdue Pending Nov 23, 2020
16538475 DESIGN OF MOLECULES HAYES, JONATHAN EDWARD 1685 §103 Final Rejection 5d overdue Pending Aug 12, 2019

Managing Recursion Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month